Credit Suisse: Regeneron Now Worth $550/Share By: Benzinga via Benzinga May 15, 2015 at 13:12 PM EDT In a report published Friday, Credit Suisse analysts maintained an Outperform rating on Regeneron Pharmaceuticals Inc (NASDAQ: REGN), ... Read More >> Related Stocks: Regeneron Pharmaceuticals